Participant flow36

How many started, completed or left each group, period by period.

21 to 36 of 36

Period	Milestone	Group	Participants
Treatment Period	STARTED	PF-04937319 10 mg	60
Treatment Period	STARTED	PF-04937319 50 mg	61
Treatment Period	STARTED	PF-04937319 100 mg	61
Treatment Period	STARTED	Glimepiride	61
Treatment Period	COMPLETED	Metformin 500 mg	0
Treatment Period	COMPLETED	Placebo	57
Treatment Period	COMPLETED	PF-04937319 10 mg	54
Treatment Period	COMPLETED	PF-04937319 50 mg	54
Treatment Period	COMPLETED	PF-04937319 100 mg	55
Treatment Period	COMPLETED	Glimepiride	54
Treatment Period	NOT COMPLETED	Metformin 500 mg	0
Treatment Period	NOT COMPLETED	Placebo	4
Treatment Period	NOT COMPLETED	PF-04937319 10 mg	6
Treatment Period	NOT COMPLETED	PF-04937319 50 mg	7
Treatment Period	NOT COMPLETED	PF-04937319 100 mg	6
Treatment Period	NOT COMPLETED	Glimepiride	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01517373/flow?page=2